PWA
NVO

Physician Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Physician Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Buy
396
+68
+21% +$2.92K ﹤0.01% 678
2026
Q1 		$12.1K Sell
328
-3
-0.9% -$142 ﹤0.01% 751
2025
Q4 		$16.8K Sell
331
-56
-14% -$2.86K ﹤0.01% 630
2025
Q3 		$21.5K Sell
387
-285
-42% -$16.7K ﹤0.01% 560
2025
Q2 		$46.4K Sell
672
-758
-53% -$51.6K 0.01% 361
2025
Q1 		$99.3K Buy
1,430
+626
+78% +$51.7K 0.02% 256
2024
Q4 		$69.2K Buy
+804
New +$86.9K 0.01% 301

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Physician Wealth Advisors's NVO Position: Q2 2026 in Review

Physician Wealth Advisors increased its Novo Nordisk (NVO) stake by 21% in Q2 2026, buying an estimated $2.92K and bringing the position to 396 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Physician Wealth Advisors first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $99.3K in Q1 2025. 302 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Physician Wealth Advisors held 396 shares of Novo Nordisk worth $19K as of Q2 2026.
  • Physician Wealth Advisors bought 68 Novo Nordisk shares in Q2 2026, an estimated $2.92K.
  • Novo Nordisk made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #678 holding.
  • Physician Wealth Advisors first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Novo Nordisk position peaked at $99.3K in Q1 2025.
  • 302 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.